14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $64.82 $75.66 Tuesday, 23rd Apr 2024 CYTK stock ended at $65.57. This is 1.09% less than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 4.93% from a day low at $65.53 to a day high of $68.76.
90 days $61.33 $84.11
52 weeks $25.98 $110.00

Historical Cytokinetics prices

Date Open High Low Close Volume
May 31, 2023 $38.11 $39.02 $37.14 $37.69 645 289
May 30, 2023 $37.19 $38.02 $36.96 $37.96 360 429
May 26, 2023 $37.38 $37.92 $37.06 $37.36 362 431
May 25, 2023 $38.06 $38.06 $36.75 $37.54 508 394
May 24, 2023 $38.79 $38.79 $37.82 $38.14 649 393
May 23, 2023 $40.69 $41.24 $38.77 $39.01 797 680
May 22, 2023 $39.16 $40.99 $39.16 $40.75 874 102
May 19, 2023 $38.28 $39.10 $37.81 $38.98 942 868
May 18, 2023 $37.80 $37.88 $36.66 $37.58 378 640
May 17, 2023 $37.45 $37.87 $36.20 $37.81 476 831
May 16, 2023 $38.29 $38.50 $36.59 $37.23 713 614
May 15, 2023 $37.79 $39.19 $37.06 $38.95 612 590
May 12, 2023 $37.74 $37.97 $36.96 $37.64 535 934
May 11, 2023 $39.50 $39.65 $37.68 $37.83 572 585
May 10, 2023 $38.84 $39.39 $38.50 $39.23 500 083
May 09, 2023 $37.99 $38.85 $37.46 $38.84 482 261
May 08, 2023 $39.61 $39.73 $37.90 $38.41 577 708
May 05, 2023 $40.97 $40.97 $37.82 $39.44 1 882 592
May 04, 2023 $40.01 $40.20 $38.40 $39.29 974 299
May 03, 2023 $37.47 $40.25 $37.15 $39.34 1 632 004
May 02, 2023 $37.77 $38.05 $36.78 $37.31 941 262
May 01, 2023 $37.36 $38.48 $37.15 $37.77 1 352 382
Apr 28, 2023 $37.87 $38.50 $37.27 $37.40 965 952
Apr 27, 2023 $37.25 $38.03 $36.74 $37.86 738 442
Apr 26, 2023 $37.94 $38.64 $36.84 $37.14 423 153
Click to get the best stock tips daily for free!

About Cytokinetics

Cytokinetics Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT